FOXO4-DRI (10mg) is D-retro-inverso peptide targeting cellular senescence. Structurally, it is a modified peptide (~3.5 kDa) synthesized with D-amino acids in reverse sequence (retro-inverso strategy) to mimic the p53-interacting domain of the FOXO4 transcription factor.
FOXO4-DRI (10mg)
Technical Specifications
FOXO4-DRI (10mg) is D-retro-inverso peptide targeting cellular senescence. Structurally, it is a modified peptide (~3.5 kDa) synthesized with D-amino acids in reverse sequence (retro-inverso strategy) to mimic the p53-interacting domain of the FOXO4 transcription factor. This preparation is manufactured to the highest standards for use in controlled laboratory research and in-vitro experimental applications.
VIP (Vasoactive Intestinal Peptide) has been studied in preclinical models for its VPAC1/VPAC2 receptor signaling, cAMP-mediated vasodilation, and anti-inflammatory cytokine modulation in neuroimmune research.
- Estimated Delivery: 5–9 business days (US)
- Returns: Store credit or reship for verified fulfillment issues
- Questions? Contact our lab support team
Shipping & Returns FAQ
Where do you ship?
We currently ship within the United States only. All orders include USPS Priority Mail tracking.
How are peptides shipped?
Products are shipped lyophilized to ensure stability during transit without refrigeration.
What is the return policy?
Store credit or reship for verified fulfillment issues. See our Shipping & Returns policy